Production Facility. During the Production Term for Phase I, CBSW will provide, in its Facility, a Production Suite, as further described in the third paragraph of Section 3 of Schedule 11.1 attached hereto, which Production Suite will be used exclusively for the manufacture of the Product.
Production Facility. The Swapped Cargo shall be loaded from a Production Facility in respect of which Transporter (on behalf of Project Co) has complied with Section 8.3.4 of the DES SPA for the relevant cargo.
Production Facility. During the Contract Period, the Collaboration Program shall be performed in the Production Facility. The System and Improvements shall be assembled, constructed and maintained in the Production Facility as more fully described and provided below. ArQule covenants that the Production Facility shall be made suitable in all respects for the performance of its duties pursuant to this Agreement and shall be maintained in such condition during the term of this Agreement.
Production Facility. Cytovance is a full-service Contract Development and Manufacturing organization (CDMO) in Oklahoma City, OK employing 220 people. Microbial host services include strain development and process development for cGMP production at the 10 L, 200 L, and 1,000 L scales, with 300 L SUF technology being added in 2018. Mammalian services include cell line development and process development for cGMP production at the 100 L, ***Confidential Treatment Requested P a g e | 14 of 18 250 L, 500 L, and 1,000 L scales with a planned expansion into 2,000 L production for early 2019. With full Analytical Development and Quality Control testing groups, Cytovance provides method transfer, development, qualification, and validation, and in-process, release, and stability testing. Cytovance also has clinical-grade, liquid vial fill/finish capabilities, Master, Working, and End-of-Production cell banking, viral validation, and Process Characterization and Validation services. Cytovance operates out of four (4) facilities - three (3) located within the Oklahoma University Research Park, close to the city’s central business district encompassing over 100,000 square feet of laboratories, cGMP Drug Product and mammalian manufacturing, and administration space. Just north of the main campus is a 30,000 ft2 microbial cGMP manufacturing building, and a 100,000 ft2 cGMP warehouse. Cytovance welcomes appropriate Synthorx representatives to tour the facilities and perform a detailed review of Cytovance’s facility design, equipment, validation, process flow, and quality systems. Analytical Test Equipment Test Quality Control Equipment Analytical Development Equipment pH Xxxxxxx 350 pH meter Xxxxxxx Toledo Conductivity Mettler Mettler Osmolality Advanced Instruments Micro-Osmometer 3300 N/A % Purity/Aggregates Waters 2695 HPLC Agilent 1100/1200 HPLC/Waters 2695 HPLC/Acquity H-Class Bio UPLC Bioburden Millipore Milliflex single head pump system Certified biological safety cabinet Precision Incubator N/A Endotoxin Molecular Devices Spectra Max 384 plus UV/Vis plate reader/ Endosafe PTS Molecular Devices Spectra Max M2e/ Endosafe PTS Protein content Xxxxxxx Xxxxxxx DU 730 spectrophotometer Molecular Devices Spectra Max 384 Plus Molecular Devices Spectra Max M2e Xxxxxxx Xxxxxxx DU 730 spectrophotometer Eppendorf Biophotometer Molecular Devices Spectra Max M2e ELISA Lab Line Instruments Titer Plate Shaker Xxxxxxx Xxxxxxx MW96/384 plate washer Molecular Devices Spectra Max 384 plus Molecular Devic...
Production Facility. The responsibility of the supplier will be to ensure the availability of production machine hardware and consumables during the entire period of operation. The Purchaser shall confirm the commencement and duration of the project to convert all old drivers licence issued to the new proposed Drivers Licence Card.
Production Facility the facilities for the production, storage, and loading of LNG onto LNG vessels and the berthing of LNG vessels, including any Gas pretreatment and processing facilities, liquefaction facilities, storage tanks, utilities, terminal facilities, and associated port and marine facilities, and all other related facilities both inside and outside the LNG plant, inclusive of all LNG production trains, including any future expansions or modifications of any such facilities described above;
Production Facility a. * agrees to dedicate at least fifteen (15) and up to twenty five (25) high temperature furnace systems for LSO crystal growth by * technique for CTI within the next 24 months starting July 1999. Such furnaces must be sufficient for the growth of LSO crystals which meet the single crystal specifications set forth in Exhibit A attached hereto.
Production Facility. Both NutraCea and FTCD has agreed that NutraCea will either install stabilization equipment at the FTCD Mill and construct one or more proprietary two stage stabilization, conversion and enhancement facilities within the Dominican Republic, or construct an additional production facility or improve an existing production facility in the United States of America sufficient to fulfill its Solubles supply obligations hereunder (“Production Facility”). If the Production Facility is constructed in the Dominican Republic and stabilization equipment is placed at the FTCD Mill, FTCD will supply all of the required raw rice bran requested by NutraCea for the purpose of stabilization of the rice bran, all on the terms and conditions set forth herein. The parties intend that the Stabilized Rice Bran, Solubles and all value-added products produced hereunder (“Products”) will be sold and commercialized by the Company, through retail outlets and distributed through government sponsored feeding programs within the Dominican Republic and Haiti (“Business”). Initially, the Products will comprise individual servings of 15 grams of NutraCea’s Solubles mixture, with such added vitamins as the parties may mutually agree upon, mixed with water and packaged for individual consumption (“Servings”). The parties may add additional products in the future by mutual agreement and shall specify any such additional Products by executing a written amendment to this Agreement.
Production Facility. NutraCea and FTCD agree to construct or improve a Production Facility for processing the Stabilized Rice Bran into bulk Stabilized Rice Bran Solubles dry mixture, which the Company will combine with water and package into the Solubles Servings, and into such other Products as the parties may hereafter mutually agree upon, from time to time. Unless the Production Facility is constructed or improved under the Alternate Production Arrangement, the facility shall be constructed to comply with the requirements and specifications agreed upon by the parties and which, once agreed upon, shall be attached as Exhibit A hereto (“Specifications”). If NutraCea and FTCD decide to proceed with the construction of the Dominican Republic Production Facility, FTCD shall grant to NutraCea a ground lease for one United States dollar ($1.00 U.S.D.) per year for land of location and quality reasonably acceptable to NutraCea and in conformity with the development criteria established by NutraCea pursuant hereto (“Land”), on which the initial Production Facility shall be constructed. The ground lease shall be a ten year lease with two ten year extensions, exercisable at the election of NutraCea and FTCD, and shall be in the form and of content reasonably acceptable to the parties. FTCD shall take all action and make all arrangements necessary or useful such that the Land has all governmental approvals, zoning, and entitlements necessary or appropriate for construction of the Production Facility and its operation as contemplated hereunder. In the alternative, NutraCea and FTCD may mutually agree to assign the Lease to the Company; with a contribution value of one United States dollar ($1.00 U.S.D.) and FTCD will have the right to terminate the Lease on any dissolution of the Company.
Production Facility. Swapped Cargo Force Majeure relief in respect of Transporter for an event affecting a Production Facility or Connecting Pipeline:
